Tenderwize
Back to tender search

Biologic rebate agreements for intravenous infliximab

Techniker Krankenkasse·Hamburg, Germany·Deadline May 30, 2028 · 652 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-11 - Infliximab (Darreichungsform zur intravenösen Anwendung)

0/100

Opportunity Score

High riskLow complexity
SuppliesOpen
Why this score?

Opportunity

0 / 100

Complexity

0 / 100

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House-Biologika-Rabattverträge 2026-11 - Infliximab (Darreichungsform zur intravenösen Anwendung)

Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Infliximab (Darreichungsform zur intravenösen Anwendung) im Rahmen eines Open-House-Verfahrens.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Procurement Details

Publication date
19 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
267510-2026

Documents (1)

Similar tenders